NEW YORK–(BUSINESS WIRE)–Under Information Relating to the Tender Offer, third paragraph,
fourth sentence ought to learn: The Tender Offer Documents could also be
downloaded from Global Bondholder Services Corporation’s web site at http://www.gbsc-usa.com/pfizer/
(as an alternative of http://www.gbsc.usa.com/pfizer/).
The corrected launch reads:
PFIZER ANNOUNCES TENDER OFFER FOR ANY AND ALL OF ITS 6.200% SENIOR
NOTES DUE MARCH 15, 2019
Pfizer Inc. (NYSE:PFE) immediately introduced the graduation of a young
supply (the “Tender Offer”) to buy for
money any and all of its excellent 6.200% Senior Notes due March 15,
2019 (the “Notes”). Certain info
relating to the Notes and the pricing for the Tender Offer is about forth in
the desk under.
| Title of Security | CUSIP Number | Principal Amount Outstanding |
U.S. Treasury Reference Security |
Bloomberg Reference Page | Fixed Spread | Hypothetical Tender Offer Consideration (1)(2) | ||||||||||||||||||
| 6.200% Senior Notes due March 15, 2019 | 717081 DB6 | $three,250,00zero,00zero | 1.00zero% UST due November 15, 2019 | FIT1 | +25 bps | $1,109.23 | ||||||||||||||||||
| (1) | Per $1,00zero principal quantity. | |
| (2) |
Hypothetical Tender Offer Consideration calculated on the idea of |
|
The Tender Offer consists of a suggestion on the phrases and circumstances set
forth within the Offer to Purchase, and the associated letter of transmittal
and discover of assured supply (as they could every be amended or
supplemented every so often, the “Tender Offer
Documents”), to buy for money any and all of the Notes. The
Company refers buyers to the Tender Offer Documents for the entire
phrases and circumstances of the Tender Offer.
The Tender Offer will expire at 5:00 p.m., New York City time, on
November 18, 2016, until prolonged or earlier terminated (such time and
date, as the identical could also be prolonged, the “Expiration
Date”). Holders of Notes should validly tender (together with by discover
of assured supply) and not validly withdraw their Notes previous to or
on the Expiration Date to be eligible to obtain the Tender Offer
Consideration.
Holders who validly tender their Notes, might validly withdraw their
tendered Notes at any time previous to the sooner of (i) the Expiration
Date, and (ii) if the Tender Offer is prolonged, the 10th
enterprise day after graduation of the Tender Offer. Notes may be
validly withdrawn at any time after the 60th enterprise day
after graduation of the Tender Offer if for any purpose the Tender
Offer has not been consummated inside 60 enterprise days after
graduation of the Tender Offer.
The “Tender Offer Consideration” for every
$1,00zero principal quantity of Notes validly tendered and accepted for
buy pursuant to the Tender Offer can be decided within the method
described within the Tender Offer Documents by reference to a hard and fast unfold
specified for the Notes (the “Fixed Spread”)
specified within the desk above plus the yield based mostly on the bid-aspect worth
of the U.S. Treasury Reference Security specified within the desk above at
2:00 p.m., New York City time, on November 18, 2016, until prolonged or
earlier terminated.
Holders will even obtain accrued and unpaid curiosity on Notes validly
tendered and accepted for buy from the final curiosity cost date
as much as, however not together with, the date the Company initially makes cost
for such Notes, which date is anticipated to be November 21, 2016 (the “Settlement
Date”). Notes tendered by discover of assured supply and
accepted for buy might be bought on the third enterprise day after
the Expiration Date however cost of accrued curiosity on such Notes will
solely be made to, however not together with, the Settlement Date.
Pfizer intends to redeem any and all Notes that aren’t tendered and
accepted within the Tender Offer in accordance with the phrases of the
make-entire provisions underneath the indenture governing the Notes.
The Tender Offer is topic to the satisfaction or waiver of sure
circumstances specified within the Tender Offer Documents, however the Tender Offer
just isn’t topic to minimal tender circumstances.
Information Relating to the Tender Offer
The Tender Offer Documents for the Notes are being distributed to
holders starting immediately. Citigroup Global Markets Inc. is the vendor
supervisor for the Tender Offer. Investors with questions relating to the
Tender Offer might contact Citigroup Global Markets Inc. at (800) 558-3745
(toll-free) or (212) 723-6106 (acquire). Global Bondholder Services
Corporation is the depositary and info agent for the Tender Offer
and might be contacted at (866) 470-4300 (toll-free) or (212) 430-3774
(acquire).
None of the Company or its associates, their respective boards of
administrators, the vendor supervisor, the depositary and info agent or
the trustee with respect to the Notes is making any suggestion as to
whether or not holders ought to tender any Notes in response to the Tender Offer,
and neither the Company nor any such different individual has approved any
individual to make any such suggestion. Holders should make their very own
determination as as to if to tender any of their Notes, and, in that case, the
principal quantity of Notes to tender.
This press launch is for informational functions solely and is just not an
supply to purchase, or the solicitation of a suggestion to promote, any of the Notes
and the Tender Offer doesn’t represent a suggestion to purchase or the
solicitation of a suggestion to promote Notes in any jurisdiction or in any
circumstances through which such supply or solicitation are illegal. The full
particulars of the Tender Offer, together with full directions on the best way to
tender Notes, are included within the Tender Offer Documents. Holders are
strongly inspired to learn rigorously the Tender Offer Documents,
together with supplies included by reference therein, as a result of they’ll
include essential info. The Tender Offer Documents could also be
downloaded from Global Bondholder Services Corporation’s web site at http://www.gbsc-usa.com/pfizer/
or obtained from Global Bondholder Services Corporation, free of cost,
by calling toll-free at (866) 470-4300 (bankers and brokers can name
gather at (212) 430-3774).
About Pfizer
At Pfizer, we apply science and our international assets to deliver therapies
to individuals that reach and considerably enhance their lives. We attempt
to set the usual for high quality, security and worth within the discovery,
improvement and manufacture of well being care merchandise. Our international
portfolio consists of medicines and vaccines in addition to many of the world’s
greatest-recognized shopper well being care merchandise. Every day, Pfizer colleagues
work throughout developed and rising markets to advance wellness,
prevention, remedies and cures that problem probably the most feared illnesses
of our time. Consistent with our duty as one of the world’s
premier progressive biopharmaceutical corporations, we collaborate with
well being care suppliers, governments and native communities to help and
increase entry to dependable, reasonably priced well being care all over the world. For
greater than 150 years, we now have labored to make a distinction for all who
depend on us.
Forward-Looking Statements
This press launch incorporates ahead-wanting statements. Such
ahead-wanting statements contain substantial dangers and uncertainties.
We have tried, wherever potential, to determine such statements through the use of
phrases comparable to “will,” “may,” “could,” “likely,” “ongoing,” “anticipate,”
“estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,”
“forecast,” “goal,” “objective,” “aim” and different phrases and phrases of
comparable which means or through the use of future dates in reference to any
dialogue of, amongst different issues, expectations relating to the completion
of the Tender Offer. An inventory and description of dangers, uncertainties and
different issues may be present in our Annual Report on Form 10-Okay for the
yr ended December 31, 2015 and in our Quarterly Reports on Form 10-Q
for the quarterly durations ended April three, 2016, July three, 2016 and October
2, 2016, in every case together with within the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future Results”
and “Risk Factors,” in our Current Reports on Form eight-Okay, and within the
prospectus complement and accompanying prospectus, in every case
together with within the part thereof captioned “Risk Factors.” You ought to
perceive that it isn’t potential to foretell or determine all such
elements. Consequently, you shouldn’t contemplate any such record to be a
full set of all potential dangers or uncertainties.
We can’t assure that any ahead-wanting assertion shall be
realized, though we consider we’ve been prudent in our plans and
assumptions. Achievement of anticipated outcomes is topic to
substantial dangers, uncertainties and inaccurate assumptions. Should
recognized or unknown dangers or uncertainties materialize, or ought to
underlying assumptions show inaccurate, precise outcomes might range
materially from previous outcomes and these anticipated, estimated or
projected. You ought to bear this in thoughts as you think about ahead-wanting
statements, and you’re cautioned to not put undue reliance on
ahead-wanting statements. We undertake no obligation to publicly
replace ahead-wanting statements, whether or not in consequence of new
info, future occasions or in any other case, besides as required by law or by
the principles and laws of the Securities and Exchange Commission (the
“SEC”). You are suggested, nevertheless, to seek the advice of any additional disclosures we
make on associated topics in our Form 10-Okay, 10-Q and eight-Okay reviews and our
different filings with the SEC.
Source link
The post CORRECTING and REPLACING Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March … – Business Wire (press release) appeared first on Utah Business Lawyer.
from
http://www.utbusinesslawyer.com/correcting-and-replacing-pfizer-announces-tender-offer-for-any-and-all-of-its-6-200-senior-notes-due-march-business-wire-press-release/
No comments:
Post a Comment